Julian Molina, MD, PhD, Mayo Clinic, Rochester, MN, emphasises the promising future of immunotherapy for solid tumors, especially melanoma and lung cancer. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.